Make It Better And Put More Money In – Industry On England’s New Innovative Medicines Fund
Executive Summary
While they await further details on England’s new Innovative Medicines Fund, industry and other stakeholders are asking questions about how far the fund – due for launch later this year – will be adapted to fit non-cancer therapies.
You may also be interested in...
Flexibility Is Key To Making England’s Innovative Medicines Fund Work
Stakeholders are calling for NHS England and NHS Improvement (NHSE&I) and the health technology assessment body NICE to bring more flexibility into England’s new Innovative Medicines Fund, which is due for launch later in 2021.
England Unveils £680m Innovative Medicines Fund
England’s Innovative Medicines Fund is aimed at providing earlier access to promising new treatments, including gene therapies, when further data is needed for routine commissioning.
UK Conservatives Promise ‘Innovative Medicines Fund’ If Re-Elected
More money to pay for innovative new medicines, more cash and support for the life sciences sector, and Brexit by 31 January 2020 are among promises made in the Conservative Party’s election platform.